Who is sponsoring NCT06300788?

NCT06300788 is sponsored by Centre Hospitalier Universitaire de Nice.

What drugs are being tested in NCT06300788?

Interventions in NCT06300788: PPI and T50 dosing.

What condition does NCT06300788 study?

NCT06300788 studies Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control.

Is NCT06300788 still recruiting?

NCT06300788 is currently recruiting now. Last updated 10 July 2025.

Last reviewed 2025-07-10 · How we verify

NCT06300788: PPi-DIA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease

Recruiting now NA Last updated 10 July 2025

What this trial tests

NA trial testing PPI and T50 dosing in Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control in 60 participants. Currently enrolling.

Timeline

27 May 2024

Primary endpoint
27 November 2026

27 November 2026

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nice
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	other
Enrollment	60
Start date	27 May 2024
Primary completion	27 November 2026
Estimated completion	27 November 2026
Sites	1 location across France

Drugs / interventions tested

PPI and T50 dosing

Conditions studied

Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control — all drugs for Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control →

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

Adults 0 to 18, any sex, with Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigator aim to identify the role of inorganic pyrophosphate and other anti-calcifying molecules in vascular disease in children with chronic kidney disease, with a view to developing therapeutic approaches aimed at limiting the onset of vasculopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Nice trials

Trials by the same sponsor.

NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06300788 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
Last refreshed: 10 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06300788.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing